Research centers on vascular inflammation, senescence, and barrier integrity across cardiometabolic and retinal disease. Uses cohort analytics, proteomics, and extracellular vesicle profiling to define biomarkers and mechanisms, and tests pharmacologic strategies that curb permeability, neovascularization, and plaque instability.